Johnson & Johnson (JNJ) Financial Analysis & Valuation | Quarter Chart

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the... more
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and se... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$624.12BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryUSCEOJoaquin Duato
IPO Date1962-01-02CAGR6.94%
Employees141,700Websitewww.jnj.com
Div. Yield1.97%Payout Ratio60%
Buy Back Yield1.23%Total Yield3.2%
JNJ chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
Enterprise Value$642.23BP/E Ratio24.16
Forward P/E20.2PEG Ratio-30.11
P/S Ratio6.64P/B Ratio8.01
P/CF Ratio28.43P/FCF Ratio35.96
EPS$10.73EPS Growth 1Y-7.7%
EPS Growth 3Y74.7%EPS Growth 5Y29.77%
Revenue Growth 1Y8.06%Gross Margin0.69%
Operating Margin0.27%Profit Margin0.22%
ROE0.26%ROA0.1%
ROCE0.18%Current Ratio1.03
Quick Ratio0.77Cash Ratio0.38
Debt/Equity0.68Interest Coverage24.92
Altman Z Score5.27Piotroski Score7

View Johnson & Johnson financial charts →

Johnson & Johnson (JNJ) valuation & financials

Johnson & Johnson (JNJ) has a market capitalization of $624.12B and trades at a price-to-earnings ratio of 24.2. It operates in the Healthcare sector (Drug Manufacturers - General).

Johnson & Johnson's revenue grew +8.1% over the last year.

Johnson & Johnson's next earnings report is scheduled for October 13, 2026 before market open; analysts estimate EPS of $3.04.

📈 Analysts estimate JNJ EPS of $3.04 for the upcoming quarter. See Johnson & Johnson revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Johnson & Johnson (JNJ) — frequently asked questions

When does Johnson & Johnson (JNJ) report earnings next?

Johnson & Johnson is expected to report earnings on October 13, 2026 before market open. Analysts estimate EPS of $3.04.

What is Johnson & Johnson's market cap?

Johnson & Johnson (JNJ) has a market capitalization of $624.12B.

What is JNJ's P/E ratio?

Johnson & Johnson trades at a price-to-earnings ratio of 24.2, with trailing twelve-month EPS of $10.73.

How fast is Johnson & Johnson growing?

Johnson & Johnson's revenue grew +8.1% over the last year.

Compare with other Healthcare companies: Eli Lilly (LLY) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW) · Novartis (NVS)

Johnson & Johnson revenue & earnings charts →